Sun Pharmaceutical Industries informs about press release

26 Nov 2025 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed the copies of the press releases titled ‘FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)’.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1808.90 -9.70 (-0.53%)
05-Dec-2025 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.90
Dr. Reddys Lab 1280.20
Cipla 1521.35
Zydus Lifesciences 933.70
Lupin 2100.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×